TACE
Clinical trials for TACE explained in plain language.
Never miss a new study
Get alerted when new TACE trials appear
Sign up with your email to follow new studies for TACE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New bead therapy may improve liver cancer treatment after shunt procedure
Disease control Recruiting nowThis phase 3 trial tests whether drug-eluting bead chemoembolization (DEB-TACE) works better than conventional chemoembolization (cTACE) for liver cancer patients who have had a TIPS procedure to manage complications of cirrhosis. The study will enroll 206 participants and track …
Matched conditions: TACE
Phase: PHASE3 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Immunotherapy plus radiation aims to stop liver cancer recurrence
Disease control Recruiting nowThis phase 3 trial tests whether combining radiotherapy with the immunotherapy drug sintilimab can better prevent liver cancer from coming back after surgery, compared to the standard TACE procedure. The study enrolls 286 adults with high-risk features like narrow surgical margin…
Matched conditions: TACE
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
AI could personalize liver cancer care after surgery
Knowledge-focused Recruiting nowThis study aims to build an AI model that uses medical images and tissue samples to predict which liver cancer patients will benefit from additional treatments after surgery. Researchers will analyze data from 11,000 patients to see if the AI's recommendations match real-world ou…
Matched conditions: TACE
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC